Research
-
Starting soon
November 2024 - May 2027
Analysis of Electroretinography using Artificial Intelligence with embedded safety features.
2024 - RESPRJ2304 - Robson -
Active
October 2024 - October 2027
Galectin-3 as a determinant of T cell-driven pathology: targeting galectin-3 to restore tissue integrity in uveitis and arthritis-associated uveitis.
2024 - RESPRJ2301 - Jones -
Active
September 2024 - September 2027
Developing mitochondrial-targeted therapies for the multisystem management of diabetic eye disease
2024 - RESPRJ2303 - Hombrebueno -
Active
September 2024 - August 2027
Tear proteomics and electrophysiology in infants at risk of retinopathy of prematurity
2024 - RESPRJ2306 - Houtman -
Active
June 2024 - November 2024
Corneal Nanoinjection: a nanoneedle platform for gene editing in inherited corneal endothelial disorders
2024 - RESPRJ2302 - Chiappini -
Active
June 2024 - May 2027
Characterisation of the smooth zone of retinal autofluorescence in the macula of choroideremia patients as a biomarker for use as an approvable endpoint in a pivotal gene therapy trial
2024 - RESPRJ2305 - MacLaren -
Active
April 2024 - March 2025
Developing an avascular zone in the Stargardt mouse retina
2024 - RESSGA2309 - Rizzi -
Active
May 2024 - May 2025
Evaluation of the efficacy of blocking light below 460 nm in protection from light-induced retinal injury in mouse models of Stargardt's disease
2024 - RESSGA2308 - Rozanowska -
Active
June 2024 - May 2025
Innovative DARC Technology: A Window into Corneal Endothelial Cell Health
2024 - RESSGA2307 - Patel